Data-driven insights are creating a massive opportunity for healthcare and life sciences organizations to deliver ground-breaking treatments and patient care. Databricks simplifies and accelerates the access and analysis of healthcare and biological data to help scientists speed up new drug development and clinicians to deliver personalized care.
At the core of this healthcare revolution is genomics data. To address the complexity and scale challenges of analyzing genomics data, Databricks is proud to introduce Unified Analytics for Genomics. With a unified platform genomic data processing, tertiary analytics, and machine learning at massive scale, organizations can accelerate the discovery of life changing treatments and drive advancements in care.
Analyzing interactions between drugs and patient genomic profile data such as mutations and gene expression changes to better predict disease drivers and accelerate therapeutic innovation.
Leverage data science to glean insights from relevant real-world healthcare data sources such as claims and electronic medical records (EMR) to improve health outcomes for patients through better treatment patterns and smarter commercialization of drugs.
Predictively determine best treatments and optimize quality of care through the aggregation and analysis of relevant patient history and care data across all healthcare channels.
Databricks provides us with a unified platform that enables
cross-team collaboration to rapidly clean and analyze a wide
variety of genomic data to accelerate drug development.